NCT02802683

Brief Summary

The purpose of this study is to compare the frequency of hypotension between hyperbaric anesthetics and isobaric anesthetics during cesarean section and determine whether continuous infusion of phenylephrine is effective in mothers who received hyperbaric anesthetics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2015

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 4, 2016

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 16, 2016

Completed
Last Updated

July 6, 2016

Status Verified

July 1, 2016

Enrollment Period

8 months

First QC Date

May 4, 2016

Last Update Submit

July 4, 2016

Conditions

Keywords

Hypotensioncesarean section

Outcome Measures

Primary Outcomes (1)

  • Number of hypotension events with treatment related

    blood pressure was obtained every 1min. A 20% decrease or more decrease in SAP compared to baseline was considered as hypotension. Hypotensive events during first 30 min was recorded as primary outcome.

    during 30min after spinal anesthesia

Secondary Outcomes (1)

  • total dose of phenylephrine

    during the surgery

Study Arms (4)

"BUPI","P"

EXPERIMENTAL

patients who received hyperbaric bupivacaine and continous infusion of phenylephrine

Drug: BupivacaineDrug: Phenylephrine

"BUPI","N"

PLACEBO COMPARATOR

patients who received hyperbaric bupivacaine and continous infusion of normal saline

Drug: BupivacaineDrug: normal saline

"LEVO","P"

EXPERIMENTAL

patients who received isobaric levobupivacaine and continous infusion of phenylephrine

Drug: LevobupivacaineDrug: Phenylephrine

"LEVO","N"

ACTIVE COMPARATOR

patients who received isobaric levobupivacaine and continous infusion of normal saline

Drug: LevobupivacaineDrug: normal saline

Interventions

spinal anesthesia with hyperbaric bupivacaine

Also known as: Heavy bupivacaine
"BUPI","N""BUPI","P"

spinal anesthesia with isobaric levobupivacaine

Also known as: chirocaine
"LEVO","N""LEVO","P"

continous infusion of phenylephrine

"BUPI","P""LEVO","P"

continous infusion of normal saline

"BUPI","N""LEVO","N"

Eligibility Criteria

Age19 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • pregnant woman scheduled for elective cesarean delivery under spinal anesthesia

You may not qualify if:

  • patients who refuse involved
  • patients who have pre-eclampsia
  • patients who have heart disease
  • patients who fetal distress is suspicious

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, Seoul, 110-744, South Korea

Location

MeSH Terms

Conditions

Hypotension

Interventions

BupivacaineLevobupivacainePhenylephrineSaline Solution

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesEthanolaminesAmino AlcoholsAlcoholsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Bahk

    Seoul National University Hospital Seoul, Korea, Republic of

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 4, 2016

First Posted

June 16, 2016

Study Start

September 1, 2015

Primary Completion

May 1, 2016

Study Completion

June 1, 2016

Last Updated

July 6, 2016

Record last verified: 2016-07

Locations